Skip to main content

Peer Review reports

From: Definitions and elements of endpoints in phase III randomized trials for the treatment of COVID-19: a cross-sectional analysis of trials registered in ClinicalTrials.gov

Original Submission
4 May 2021 Submitted Original manuscript
7 Jun 2021 Reviewed Reviewer Report - Tra My Pham
8 Jun 2021 Reviewed Reviewer Report - Riaz Qureshi
15 Jun 2021 Reviewed Reviewer Report - Conor Tweed
15 Aug 2021 Author responded Author comments - Kentaro Sakamaki
Resubmission - Version 2
15 Aug 2021 Submitted Manuscript version 2
22 Aug 2021 Reviewed Reviewer Report - Riaz Qureshi
6 Sep 2021 Reviewed Reviewer Report - Tra My Pham
9 Sep 2021 Reviewed Reviewer Report - Conor Tweed
15 Oct 2021 Author responded Author comments - Kentaro Sakamaki
Resubmission - Version 3
15 Oct 2021 Submitted Manuscript version 3
20 Oct 2021 Reviewed Reviewer Report - Tra My Pham
25 Oct 2021 Reviewed Reviewer Report - Riaz Qureshi
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
26 Oct 2021 Editorially accepted
8 Nov 2021 Article published 10.1186/s13063-021-05763-y

You can find further information about peer review here.

Back to article page